The Lenalidomide Drug Market is poised for steady expansion, driven by rising demand in key therapeutic areas and improving access to treatment. According to The Insight Partners, the market is anticipated to expand at a CAGR of 6% from 2026 to 2034. This growth reflects increasing clinical adoption, favorable reimbursement policies, and ongoing developments in oncology...